Dermorphin

Dermorphin is a heptapeptide opioid originally isolated from frog skin. This peptide has high selectivity for mu-opioid receptors. Researchers study Dermorphin for its potent analgesic effects, receptor binding properties, and opioid system interactions in laboratory settings.

Research on Dermorphin examines its opioid receptor binding and analgesic mechanisms. Studies focus on its selective mu-opioid receptor activation, pain modulation pathways, receptor pharmacology, and comparison with other opioid peptides. Researchers investigate its mechanisms involving G-protein coupled receptor signaling, pain pathway modulation, and structure-activity relationships in experimental models.